Examine the Issues Faced by the World's Generic Companies.DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c47615) has announced the addition of the Espicom Business Intelligence Introduction Espicom Business Intelligence is a publisher of independent and impartial information and analysis services focusing on the pharmaceutical and medical device markets. Ltd report: World Generic Market Report 2007 to their offering. The World Generic Market Report 2007. is packed with facts, figures, analysis and statistics, the 480+ page report provides the most thorough report available on generic markets, products and companies and the issues they face. The changing face of the generics industry The pace of corporate consolidation grows ever faster. Nine acquisitions were announced in 2006 including well known companies such as Andrx and Pliva. Increasingly the industry is being rationalised and dominated by fewer and fewer larger players. Teva and Sandoz may be fighting it out for the top spot but the speed of change is seeing the corporate landscape change continuously. Emerging markets to 2011 Established generic markets may currently account for the bulk of generic prescribing and value, but where is the industry going in the future? In terms of growth not one of the leading markets features, but look to France, Spain, Brazil and Italy if you want significant double digit Noun 1. double digit - a two-digit integer; from 10 to 99 integer, whole number - any of the natural numbers (positive or negative) or zero; "an integer is a number that is not a fraction" growth to 2011. Topics Covered: * Strides enters agreement with Stada in the US * Stada acquires Portuguese generics supplier * Orchid enters US market agreement with Stada Pharmaceuticals * Stada acquires Nizhpharm Teva Pharmaceutical Industries Teva Pharmaceutical Industries Ltd. (Hebrew: טבע תעשיות פרמצבטיות בע"מ), NASDAQ: TEVA is an international pharmaceutical company headquartered in - Introduction - Background - Teva to close Puerto Rican Puer·to Ri·co Abbr. PR or P.R. A self-governing island commonwealth of the United States in the Caribbean Sea east of Hispaniola. manufacturing facility - Products - Financials - Segment Data - Geographic Segment - Major developments - Teva increases stake in Hualida - Teva completes IVAX IVAX Industrial Vax (Dec Computer) acquisition; Par and Barr benefit - Teva and Barr sign agreement covering fexofenadine - Teva and TransPharma sign transdermal drug delivery agreement - Dorom - Microbia - Sicor - Impax Towa Pharmaceutical - Introduction - Background - Products - Financials - Major developments - Eisai's lawsuit against manufacturers/distributors of generic Selbex dismissed - Japanese Generic companies form agreement for stable generic supply Watson Pharmaceuticals Watson Pharmaceuticals, Incorporated (NYSE: WPI) is the 5th largest pharmaceutical company in the United States based on number of prescriptions dispensed. Based in Corona, California, Watson's Generics division markets over 150 pharmaceutical product families, including one of the - Introduction - Background - New business strategy- Watson to acquire Andrx - Watson to divest Arizona injectable in·ject·a·ble adj. Capable of being injected. Used of a drug. n. A drug or medicine that can be injected. manufacturing facility - Further restructuring announced, Puerto Rico plant to close - Watson dedicates new distribution facility - Products - Financials - Major developments - Watson completes acquisition of Sekhsaria Chemicals - Watson to acquire Andrx - Other acquisitions and collaborations - Watson to distribute OxyContin Ox·y·con·tin A trademark for the drug oxycodone. oxycodone hydrochloride ETH-Oxydose, OxyContin, OxyFast, Oxy-IR, Oxynorm (UK), Roxicodone, Supeudol (CA) Pharmacologic class: Opioid agonist authorised generic - Interpharm and Watson commence ibuprofen ibuprofen (ī`by prō'fən), nonsteroidal anti-inflammatory drug (NSAID) that reduces pain, fever, and inflammation. manufacturing and supply agreement - Bupropion bupropion /bu·pro·pi·on/ (bu-pro´pe-on) a monocyclic compound structurally similar to amphetamine, used as the hydrochloride salt as an antidepressant and as an aid in smoking cessation. authorised generic agreement with GSK GSK GlaxoSmithKline plc (pharmaceutical company)GSK Glycogen Synthase Kinase GSK Gruppentraining Sozialer Kompetenzen (Germany) GSK Greenland Shark (FAO fish species code) Winthrop Pharmaceuticals - Introduction - Background - Czech Republic - France - Germany - Portugal - United Kingdom - Products - Financials - Major Developments Wockhardt - Introduction - Background - Wockhardt receives warning letter from the FDA FDA abbr. Food and Drug Administration FDA, n.pr See Food and Drug Administration. FDA, n.pr the abbreviation for the Food and Drug Administration. - Products - Financials - Major developments - Wockhardt to raise up to US$ million to fund overseas acquisitions - Pharmaceutical plants - Joint Ventures - Mergers, acquisitions and agreements Zentiva - Introduction - Background - Products - Financials - Major developments - sanofi-aventis - Sicomed Zydus Cadila - Introduction - Background - Products - Financials - Major Developments - Evolupharn and Aerocid - Joint venture with Bharat Serums and Vaccines - Joint venture with Mayne Pharma - Venus Remedies - Alliance with Mallinckrodt - MoU with Zambon - Alpharma France - Merger into Cadila Healthcare Sources Directory Regulators Industry Associations Manufacturers - Australia - Canada - Croatia - Czech Republic - France - Germany - Hungary - Iceland - India - Israel Companies Mentioned: - Apotex - Aspen Pharmacare - Barr Laboratories - Cipla - Dr Reddy's - EGIS - Hospira - KRKA - Lannett - Mayne Pharma - Merck Generics - Mylan Labs - Par Pharmaceuticals - Perrigo - Pliva - Ranbaxy - ratiopharm - Gedeon Richter - Sandoz - Sawai - Stada Arzneimittel - Teva Pharmaceutical Industries - Towa Pharmaceuticals - Watson Pharmaceuticals - Winthrop - Wockhardt - Zentiva - Zydus Cadila For more information visit http://www.researchandmarkets.com/reports/c47615 |
|
||||||||||||||

prō'fən)
Printer friendly
Cite/link
Email
Feedback
Reader Opinion